Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture

Endocrinology

Volumn 140, Issue 6, 1999, Pages 2876-2882

  Maret, Arlette ^a   Clamens, Simone ^a   Delrieu, Isabelle ^a   Elhage, Rima ^a   Arnal, Jean François ^a   Bayard, Francis ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOKINE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SITE DIRECTED MUTAGENESIS; VASCULAR SMOOTH MUSCLE;

EID: 0033279168     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.6.6763     Document Type: Article

References (60)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. International consensus conference on post-menopausal therapy and the cardiovascular system
3. Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
4. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys. Lack of an effect of added progesterone
5. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
6. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
7. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice
8. 17β-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice
9. Estrogen synthesis, estrogen metabolism and functional estrogen receptors in rat arterial smooth muscle cells in culture
10. Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells
11. Estrogens modulate bovine vascular endothelial cell permeability and heat shock protein 25 expression concomitantly
12. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
13. Molecular bases of the acute coronary syndromes
14. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats
15. Interleukin 6 transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
16. IL-1 stimulates IL-6 production in endothelial cells
17. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6
18. Endothelin-induced interleukin-6 production by rat aortic endothelial cells
19. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL6
20. Cytokine-induced production of IFN-β2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17β
21. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
22. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
23. Interleukin-6: An overview
24. Molecular regulation of B lymphocyte response
25. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
26. Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells
27. IL-6 increases endothelial permeability in vitro
28. Interaction of monocytes with coculture of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message
29. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function
30. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
31. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
32. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice
33. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
34. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation
35. Isolation and characterization of biologically active murine interleukin-6 produced in Escherichia coli
36. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
37. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice
38. Adaptation of the human breast cancer line MCF-7 to serum free medium culture on extracellular matrix
39. T-cell growth factor: Parameters of production and a quantitative microassay for activity
40. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
41. Activation of the interleukin 6 gene by mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kB
42. The complete primary structure of human estrogen receptor beta (hERβ) and its heterodimerisation with ERα in vivo and in vitro
43. A simple phase-extraction assay for chloramphenicol acyltransferase activity
44. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells
45. Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor
46. Correction immunology
47. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
48. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
49. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor
50. Involvement of CCAAT/enhancer-binding protein and nuclear factor-κβ binding sites in interleukin-6 promoter inhibition by estrogens
51. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
52. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
53. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence
54. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
55. Epidermal growth factor and okadaic acid stimulates Sp1 proteolysis
56. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
57. The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
58. Vascular smooth muscle cells express a constitutive NF-κB-like activity
59. A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBPβ and an Sp1 factor
60. Expression of interleukin-6 in atherosclerotic lesions of male apoE-knockout mice